Xavier M. Keutgen - Concepedia

Author

Xavier M. Keutgen

Also Known As

Keutgen, X.M., Keutgen, Xavier M, X Keutgen, X. Keutgen, X. M. Keutgen, X.M. Keutgen, XAVIER KEUTGEN, Xavier Keutgen, Xavier M Keutgen, Xavier M. Keutgen

130

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Rush University Medical Center National Cancer Institute National Institutes of Health Cornell University University of Chicago

About

Xavier M. Keutgen is an author at Rush University Medical Center specializing in medicine, surgery, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	19	910
2	Health Sciences	2	2	53
3	Engineering	1	1	155
4	Biostatistics	1	1	155
5	Cell Biology	1	1	61

Xavier M. Keutgen

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors James R. Howe, Nipun B. Merchant, Claudius Conrad, Pancreas	2019	368
A Panel of Four miRNAs Accurately Differentiates Malignant from Benign Indeterminate Thyroid Lesions on Fine Needle Aspiration Xavier M. Keutgen, Filippo Filicori, Michael J. Crowley, Clinical Cancer Research	2012	156
A general method to derive robust organ-specific gene expression-based differentiation indices: application to thyroid cancer diagnostic G. Tomás, Maxime Tarabichi, David Gacquer, Oncogene BioinformaticsEngineeringMedicineGeneticsThyroid Disease	2012	155
Resection of primary tumor site is associated with prolonged survival in metastatic nonfunctioning pancreatic neuroendocrine tumors Xavier M. Keutgen, Naris Nilubol, Joanne Glanville, Surgery Surgical OncologyPancreatic CancerMedicinePrimary Tumor SitePancreatic Surgery	2015	115
Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors John F. Tierney, Sitaram V. Chivukula, Xuanji Wang, Surgery Surgical OncologyMedicineNeuroendocrine DisorderEndocrine SurgerySurgery	2018	110
Prognostic Utility of Total 68Ga-DOTATATE-Avid Tumor Volume in Patients With Neuroendocrine Tumors Amit Tirosh, Georgios Z. Papadakis, Corina Millo, Gastroenterology MedicineNeuroendocrine DisorderPathologyPrognostic UtilityNeuroendocrine Tumors	2017	85
Intercellular Adhesion Molecule-1 (ICAM-1) is Upregulated in Aggressive Papillary Thyroid Carcinoma Daniel Buitrago, Xavier M. Keutgen, Michael J. Crowley, Annals of Surgical Oncology MedicineCell AdhesionPathologyIntercellular Adhesion Molecule-1Tumor Suppressor	2011	61
Deep learning prediction of BRAF-RAS gene expression signature identifies noninvasive follicular thyroid neoplasms with papillary-like nuclear features James M. Dolezal, Anna Trzcinska, Chih‐Yi Liao, Modern Pathology	2020	59
Dicer expression and microRNA dysregulation associate with aggressive features in thyroid cancer Piril Erler, Xavier M. Keutgen, Michael J. Crowley, Surgery Aggressive FeaturesThyroid DiseasePathologyCancer GenomicsThyroid Cancer	2014	52
Malignant-functioning neuroendocrine tumors of the pancreas: A survival analysis Xavier M. Keutgen, Naris Nilubol, Electron Kebebew Surgery Pancreatic CancerMedicineHistopathologyPathologyNeuroendocrine Tumors	2015	52

Page 1